MRD / Regn No. : BNH/23-24/01068 Date : 30/06/2026
Patient Name : TEJASWI Age & Gender : 55 Yrs. / Male
Contact No. : 8073565640 UHID :
Ht / Wt / BMI : / 66 / BP S / BP D : 120 / 70
Allergies : NIL Referred By :
   
Subjective : ,ASYMPTOMATIC NOW POST STENTING,PRIMARY PCI TO RCA IN DEC 2024
Analysis : TOTAL CHOLESTEROL-178,TRIGLYCERIDES- 216,HDL CHOLESTEROL-50,LDL CHOLESTEROL-84.8,30/06/26,HBA1C-8.1,CHOLESTEROL-185,TRIGLYCERIDES-217,HDL-42,LDL-99.6,CREATININE-0.82,URIC ACID-6.4,LP[A]15.1
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET ATORVASTATIN
STORVAS 80MG
ORAL 0-0-1 AFTER FOOD
TILL NEXT VISIT
2 COSATYL 1000 MG ORAL 2-0-2 AFTER FOOD
3 TABLET GLICLAZIDE + METFORMIN
DIAMICRON XR MEX 60/500 MG
ORAL 1-0-1 AFTER FOOD
4 CAPSULE SITAGLIPTIN , DAPAGLIFLOZIN,METFORMIN HYDROCHLORIDE
OXRAMET S XR 1000
ORAL 0-0-1 AFER FOOD
5 CAPSULE BEMPIDOIC ACID + EZETEMIBE
BEMPESTA EZ
ORAL 1-0-0 AFER FOOD
6 TABLET PANTOPRAZOLE
PANTOCID 40
ORAL 1-0-0 30 MIN BEFORE FOOD
X 10 DAYS
7 CAPSULE INCLISIRAN
INJ CRENZLO- 284 MG S/C
ONCE IN 6 MONTHS, STAT, REPEAT X 3 MONTHS
8 TABLET CLOPIDOGREL + ASPIRIN
DEPLATT A 75MG
1-0-0 ( 4 TABS ON FIRST DAY) AFTER FOOD
TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 28/Oct/2026
Tests Suggested For Next Visit : RPT FASTING LIPID PROFILE,HBA1C X 3 MONTHS
   
   

Dr. V. S. Prakash
MD, DM, FISE, FSCAI, FACC, FESC
Karnataka / 21756

This is a Computer generated Prescription

Powered By: